Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lara

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cancer Research|December 20, 2018
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i>-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkMarta Román, Inés López, Elisabeth Guruceaga, et al.
Cell Genomics|December 12, 2024
scTrends: A living review of commercial single-cell and spatial 'omic technologiesJoachim De Jonghe, James W Opzoomer, Amaia Vilas-Zornoza, et al.
Nature Communications|November 26, 2025
Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screensLaura Pilar Aguado-Alvaro, Nerea Garitano, Wolfgang Esser-Skala, et al.
Circulation|September 25, 2020
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial InfarctionAdrián Ruiz-Villalba, Juan P Romero, Silvia C Hernández, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Blood|April 24, 2020
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myelomaCristina Perez, Cirino Botta, Aintzane Zabaleta, et al.
Nature Communications|December 9, 2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.
Blood|June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell developmentDaniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Genome Research|August 22, 2020
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaRaquel Ordoñez, Marta Kulis, Nuria Russiñol, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cancer Research|December 20, 2018
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i>-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkMarta Román, Inés López, Elisabeth Guruceaga, et al.
Cell Genomics|December 12, 2024
scTrends: A living review of commercial single-cell and spatial 'omic technologiesJoachim De Jonghe, James W Opzoomer, Amaia Vilas-Zornoza, et al.
Nature Communications|November 26, 2025
Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screensLaura Pilar Aguado-Alvaro, Nerea Garitano, Wolfgang Esser-Skala, et al.
Circulation|September 25, 2020
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial InfarctionAdrián Ruiz-Villalba, Juan P Romero, Silvia C Hernández, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Blood|April 24, 2020
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myelomaCristina Perez, Cirino Botta, Aintzane Zabaleta, et al.
Nature Communications|December 9, 2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.
Blood|June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell developmentDaniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Genome Research|August 22, 2020
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaRaquel Ordoñez, Marta Kulis, Nuria Russiñol, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Pageof 6